Monoclonal Anti HCG 40nm OD10 100ml

Added to your cart

Monoclonal Anti HCG 40nm OD10 100ml

Cart subtotal: £0.00

View cart (0) Checkout


Get in touch to purchase this product

Contact our team of experts to discuss your requirements

Contact our expert team

Product Details

hCG is part of the fertility Gold Conjugate family. Human Chorionic Gonadotrophin (hCG) is a hormone produced in pregnancy soon after conception. It is the standard marker for early pregnancy testing. The BBI conjugate (BA.HCG40) and matched pair capture (01041131C) are designed for use in human urine, not serum. The monoclonal capture antibody (01041131C) recognises the beta chain and beta core fragment of hCG. Its purity is >95% and doesn't cross recat with with alpha hCG, FSH or TSH. The conjugate is suspended in a low molarity buffer 2mM Borax pH7.2 containing 0.095% Sodium Azide as a preservative. All gold conjugate products are available at OD10 in volumes of 5, 50, 100 or 500mls unless stated otherwise. Customised concentrations of conjugates with an OD other than OD10, are available by request.

More information



  • Shipping Information
  • If you are based outside of the EU there will be a 5 day lead time added to your order to enable us to comply with the Animal and Plant Health Agency (APHA) export/import policy
  • Specification
  • OD10, Mean Particle Diameter 37 - 43nm, % CV≤ 8.0%
  • Recommended Use
  • Lateral Flow
  • Preservatives
  • 0.095% azide
  • Lead Time
  • 2 weeks
  • Optical Density
  • OD10
  • Particle Size
  • 40nm

Technical Documents

Safety Data Sheet (82.52KB)

Product Information (384.96KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands


The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.


Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.


Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox